118 results
D
KPRX
Kiora Pharmaceuticals Inc
14 Feb 24
$15.00 mm in equity / options / securities to be acquired, sold $15.00 mm, 13 investors
3:51pm
that are the subject of this Form D are "covered securities" for purposes
of NSMIA, whether in all instances or due to the nature of the offering
8-K
EX-10.1
KPRX
Kiora Pharmaceuticals Inc
1 Feb 24
Kiora Pharmaceuticals Announces Private Placement of up to Approximately $45 Million
7:01am
to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business … had not occurred. 5.17 Independent Nature of Purchasers’ Obligations and Rights. The obligations of each Purchaser under any Transaction Document
8-K
EX-10.2
hu35n9czlw v90cfec
1 Feb 24
Kiora Pharmaceuticals Announces Private Placement of up to Approximately $45 Million
7:01am
8-K
EX-10.1
cu73hakhi5ilynho6nwa
31 Jan 24
Entry into a Material Definitive Agreement
5:14pm
8-K
EX-10.2
qqijcvjcku 75gy
15 Jun 23
Kiora Pharmaceuticals and Sentrx Animal Care Amend Existing Manufacturing Licensing Agreement for KIO-201
4:59pm
8-K
EX-10.1
k45euv0xt1vk kr
15 Jun 23
Kiora Pharmaceuticals and Sentrx Animal Care Amend Existing Manufacturing Licensing Agreement for KIO-201
4:59pm
8-K
EX-1.1
i5p 7ux5va6pc6
6 Jun 23
Kiora Pharmaceuticals Announces Pricing of $5.5 Million Underwritten Public Offering
4:52pm
424B1
rf0ai
2 Jun 23
Prospectus with pricing info
5:08pm